Shares of Liberty Biopharma Inc (CVE:LTY – Get Free Report) passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares traded.
Liberty Biopharma Stock Up ?
The stock’s 50-day moving average price is C$2.00 and its two-hundred day moving average price is C$2.00. The company has a current ratio of 0.12, a quick ratio of 0.12 and a debt-to-equity ratio of 8.19. The stock has a market capitalization of C$21.54 million and a P/E ratio of -12.66.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Recommended Stories
- Five stocks we like better than Liberty Biopharma
- What to Know About Investing in Penny Stocks
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- What is the Shanghai Stock Exchange Composite Index?
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Health Care Stocks Explained: Why You Might Want to Invest
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
